Abstract
γ-Glutamylcyclotransferase (GGCT), which is one of the major enzymes involved in glutathione metabolism, is upregulated in a wide range of cancers-glioma, breast, lung, esophageal, gastric, colorectal, urinary bladder, prostate, cervical, ovarian cancers and osteosarcoma-and promotes cancer progression; its depletion leads to the suppression of proliferation, invasion, and migration of cancer cells. It has been demonstrated that the suppression or inhibition of GGCT has an antitumor effect in cancer-bearing xenograft mice. Based on these observations, GGCT is now recognized as a promising therapeutic target in various cancers. This review summarizes recent advances on the mechanisms of the antitumor activity of GGCT inhibition.
References
Aug 1, 1974·Annals of Internal Medicine·A Meister
Nov 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·M Orlowski, A Meister
Feb 7, 2004·Clinical Chemistry·Susumu KageyamaTatsuhiro Yoshiki
Jun 13, 2006·Biochemical and Biophysical Research Communications·Yutaka MasudaKazuyasu Nakaya
Aug 1, 2007·BMC Bioinformatics·Lei XuRaimond L Winslow
Jun 3, 2008·The Journal of Biological Chemistry·Aaron J OakleyPhilip G Board
Aug 19, 2009·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Keisuke OdaIkuo Tooyama
Jun 10, 2010·Journal of Proteome Research·Pavel GromovJosé M A Moreira
Feb 1, 2007·Proteomics. Clinical Applications·Susumu KageyamaTatsuhiro Yoshiki
May 1, 2009·Molecular Medicine Reports·Kaoru AzumiHideyoshi Yokosawa
Sep 3, 2011·The FEBS Journal·Yuji OhnoHideaki Kakeya
Nov 15, 2011·Life Sciences·Yukiko K NakamuraStanley T Omaye
Dec 30, 2011·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Tomonari AmanoPhilip G Board
Jun 2, 2012·Cancer Gene Therapy·S HamaK Kogure
Jul 16, 2013·Journal of Biochemistry·Yuji OhnoHideaki Kakeya
Oct 12, 2013·Chembiochem : a European Journal of Chemical Biology·Taku YoshiyaYuji Nishiuchi
Dec 18, 2013·Human Pathology·Kosuke TakemuraPhilip G Board
Jun 30, 2014·Advances in Cancer Research·Yilin LiuJoseph J Barycki
Sep 27, 2014·Journal of Pharmaceutical Sciences·Rui RanQin He
Feb 5, 2015·Organic & Biomolecular Chemistry·Taku YoshiyaYuji Nishiuchi
May 6, 2015·Cancer Biotherapy & Radiopharmaceuticals·Zhifeng LinQiang Lin
Sep 5, 2015·BioMed Research International·Susumu KageyamaAkihiro Kawauchi
Feb 2, 2016·Biochemical and Biophysical Research Communications·Shang-Hang ShenZhan-Xiang Wang
Jul 5, 2016·Chemical & Pharmaceutical Bulletin·Hiromi IiJun'ichi Uenishi
Aug 9, 2016·Anti-cancer Drugs·Jian DongYue Li
Sep 24, 2016·BMC Cancer·Kengo MatsumuraTatsuhiro Yoshiki
Dec 3, 2016·BMC Biochemistry·Wenjie ZhangWenjie Lv
Feb 16, 2017·Journal of Peptide Science : an Official Publication of the European Peptide Society·Taku YoshiyaTatsuhiro Yoshiki
Jan 9, 2018·Biochemical and Biophysical Research Communications·Keiko TaniguchiSusumu Nakata
Jan 10, 2018·ChemMedChem·Hiromi IiTatsuhiro Yoshiki
Feb 13, 2018·Gynecologic Oncology·Yanli LiSufang Wu
Citations
Oct 20, 2020·Frontiers of Medicine·Deyu ZhangQinong Ye
Jan 7, 2021·Cancer Gene Therapy·Keiko TaniguchiSusumu Nakata
Feb 19, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Chit TamChi Chiu Wang
Mar 7, 2021·Biochemical and Biophysical Research Communications·Hiromi IiSusumu Nakata
Sep 7, 2021·Frontiers in Genetics·Zhihao ZouYuxiang Liang
Dec 5, 2021·Molecular Pharmacology·Hiroko TakagiSusumu Nakata